Covid bulletin header
Due to the evolving nature of guidance, please note that information is correct at the time of each bulletin.
Bulletin 140 (10-06-21)
- Management of Covid-19 vaccination clinical Incidents: Briefing for Trust Clinicians
- Restrictions on Lift Capacity
- Travelling Abroad
Useful links for staff:
- Support for Staff hub
- Advice and FAQs for staff section
- Working remotely? We’re making these bulletins available here for staff working remotely. If you need help with MS Teams, help guides can be found here.
In light of several recent potential vaccine related incidents, I am writing to confirm the actions you should take to ensure patients receive best care and to enable incidents to be monitored and escalated appropriately. Please see the algorithms for advice:
All significant adverse events and reactions to Covid-19 vaccines must be reported to Datix.
These include, but are not limited to:
- Any side-effect/ reaction that is not already noted in the manufacturer’s SPC and that the clinician considers to be possibly linked chronologically to the vaccination.
- A known side-effect/reaction noted on the SPC but that the clinician considers to be an extreme form of this known side-effect, e.g. Fever that lasts more than expected number of days, and for which there is no other cause, an urticarial reaction that affects a much larger area than just at the injection site etc.
- An acute clinical event or hospitalisation linked in time to the vaccination for which the clinician does not consider there to be any other clinical cause.
When reporting incidents which may be related to the Covid-19 vaccination programme to Datix, please ensure ‘COVIDVACC’ is written in the ‘Insert a brief summary of the Incident and the consequences’ field of the Incident form before the incident is described. This will help the national vaccination team to rapidly locate incidents which require their review.
Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) cases
For possible Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) cases, Clinicians are required to follow the diagnostic flow chart.
For all possible VITT cases, confirmed by present acute thrombosis AND Platelet count <150x10*9/I, Clinicians are required to refer to the On-call Haematologist and to escalate to CARS (Clinical Advice and Response Service)* via firstname.lastname@example.org
*This reporting system is a collaboration between Public Health England, NHS England and NHS Improvement (NHSE&I) and MHRA.
CARS will allocate a unique reference number when the Incident is reported and will advise on which additional reporting should be completed following initial review of the information provided. Please share this reference number and information regarding additional reporting requirements with the On-call Haematologist.
If in doubt regarding a clinical case, please liaise with the On-call Haematologist.
Mr Paul McArdle
Deputy Medical Director
Contrary to popular rumour, the restrictions on lift capacity at the hospital remain a maximum of 4 people per lift. Signage is being refreshed and replenished and your support in maintaining safe social distancing is appreciated.
The current Government advice in terms of quarantine is here . Where quarantine rules apply, quarantine absence following a holiday abroad can be taken as either annual leave, TOIL or unpaid leave (unless arrangements for remote working can be made). We understand that this is a particularly difficult time for our colleagues from overseas who at some point may want to visit family at home. This is likely to require a different approach to that of taking leave for a holiday. We are asking line managers to consider these requests sympathetically, and quarantine periods are supported through colleagues working from home (where possible) or with special pay.
If colleagues are considering booking future leave which involves travelling abroad, this will clearly have an impact on the management of leave across teams. Please discuss this in advance with your Line Manager to determine whether the potential duration away from the workplace (both annual leave and any potential quarantine absence) is supported and authorised and, what your quarantine arrangements will be.
Trust policy and Guidance
Trustwide COVID-19 Patient Screening Assessment.pdf [pdf] 395KB Updated 11.01.2021
De-escalation and patient discharge
Staff track and trace website (only accesible from Trust devices)